ARTICLE | Clinical News
NCX 1022: Phase I data
October 8, 2007 7:00 AM UTC
NicOx S.A. (Euronext:COX), Sophia-Antipolis, France Ferrer Internacional S.A., Barcelona, Spain Product: NCX 1022 Business: Dermatology Molecular target: Cyclooxygenases (COX) Description: Nitric ox...